vs
Side-by-side financial comparison of AVIENT CORP (AVNT) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.
AVIENT CORP is the larger business by last-quarter revenue ($760.6M vs $617.8M, roughly 1.2× Hims & Hers Health, Inc.). Hims & Hers Health, Inc. runs the higher net margin — 3.3% vs 2.2%, a 1.1% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs 1.9%). AVIENT CORP produced more free cash flow last quarter ($125.4M vs $-2.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs -4.2%).
Avient Corporation is a global materials solutions company headquartered in Avon Lake, Ohio, United States, employing approximately 9,000 people worldwide. Its products include colorants, advanced composites, functional additives and engineered materials.
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
AVNT vs HIMS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $760.6M | $617.8M |
| Net Profit | $16.9M | $20.6M |
| Gross Margin | 30.2% | 71.9% |
| Operating Margin | 5.2% | 1.5% |
| Net Margin | 2.2% | 3.3% |
| Revenue YoY | 1.9% | 28.4% |
| Net Profit YoY | -65.0% | -20.8% |
| EPS (diluted) | $0.18 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $760.6M | $617.8M | ||
| Q3 25 | $806.5M | $599.0M | ||
| Q2 25 | $866.5M | $544.8M | ||
| Q1 25 | $826.6M | $586.0M | ||
| Q4 24 | $746.5M | $481.1M | ||
| Q3 24 | $815.2M | $401.6M | ||
| Q2 24 | $849.7M | $315.6M | ||
| Q1 24 | $829.0M | $278.2M |
| Q4 25 | $16.9M | $20.6M | ||
| Q3 25 | $32.6M | $15.8M | ||
| Q2 25 | $52.6M | $42.5M | ||
| Q1 25 | $-20.2M | $49.5M | ||
| Q4 24 | $48.3M | $26.0M | ||
| Q3 24 | $38.2M | $75.6M | ||
| Q2 24 | $33.6M | $13.3M | ||
| Q1 24 | $49.4M | $11.1M |
| Q4 25 | 30.2% | 71.9% | ||
| Q3 25 | 30.4% | 73.8% | ||
| Q2 25 | 32.1% | 76.4% | ||
| Q1 25 | 31.8% | 73.5% | ||
| Q4 24 | 34.8% | 76.8% | ||
| Q3 24 | 32.1% | 79.2% | ||
| Q2 24 | 30.3% | 81.3% | ||
| Q1 24 | 33.6% | 82.4% |
| Q4 25 | 5.2% | 1.5% | ||
| Q3 25 | 8.3% | 2.0% | ||
| Q2 25 | 11.1% | 4.9% | ||
| Q1 25 | 0.1% | 9.9% | ||
| Q4 24 | 11.5% | 3.9% | ||
| Q3 24 | 9.5% | 5.6% | ||
| Q2 24 | 8.5% | 3.5% | ||
| Q1 24 | 11.3% | 3.6% |
| Q4 25 | 2.2% | 3.3% | ||
| Q3 25 | 4.0% | 2.6% | ||
| Q2 25 | 6.1% | 7.8% | ||
| Q1 25 | -2.4% | 8.4% | ||
| Q4 24 | 6.5% | 5.4% | ||
| Q3 24 | 4.7% | 18.8% | ||
| Q2 24 | 4.0% | 4.2% | ||
| Q1 24 | 6.0% | 4.0% |
| Q4 25 | $0.18 | $0.08 | ||
| Q3 25 | $0.36 | $0.06 | ||
| Q2 25 | $0.57 | $0.17 | ||
| Q1 25 | $-0.22 | $0.20 | ||
| Q4 24 | $0.53 | $0.10 | ||
| Q3 24 | $0.41 | $0.32 | ||
| Q2 24 | $0.36 | $0.06 | ||
| Q1 24 | $0.54 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $228.6M |
| Total DebtLower is stronger | $1.9B | — |
| Stockholders' EquityBook value | $2.4B | $540.9M |
| Total Assets | $6.0B | $2.2B |
| Debt / EquityLower = less leverage | 0.81× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $228.6M | ||
| Q3 25 | — | $345.8M | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $273.7M | ||
| Q4 24 | — | $220.6M | ||
| Q3 24 | — | $165.5M | ||
| Q2 24 | — | $129.3M | ||
| Q1 24 | — | $105.2M |
| Q4 25 | $1.9B | — | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $2.0B | — | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — | ||
| Q1 24 | $2.1B | — |
| Q4 25 | $2.4B | $540.9M | ||
| Q3 25 | $2.4B | $581.0M | ||
| Q2 25 | $2.4B | $562.7M | ||
| Q1 25 | $2.3B | $549.3M | ||
| Q4 24 | $2.3B | $476.7M | ||
| Q3 24 | $2.4B | $440.1M | ||
| Q2 24 | $2.3B | $362.0M | ||
| Q1 24 | $2.3B | $344.5M |
| Q4 25 | $6.0B | $2.2B | ||
| Q3 25 | $6.1B | $2.2B | ||
| Q2 25 | $6.1B | $1.9B | ||
| Q1 25 | $5.8B | $891.7M | ||
| Q4 24 | $5.8B | $707.5M | ||
| Q3 24 | $6.0B | $602.3M | ||
| Q2 24 | $5.9B | $480.5M | ||
| Q1 24 | $5.9B | $448.1M |
| Q4 25 | 0.81× | — | ||
| Q3 25 | 0.83× | — | ||
| Q2 25 | 0.86× | — | ||
| Q1 25 | 0.90× | — | ||
| Q4 24 | 0.89× | — | ||
| Q3 24 | 0.88× | — | ||
| Q2 24 | 0.90× | — | ||
| Q1 24 | 0.90× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $167.8M | $61.3M |
| Free Cash FlowOCF − Capex | $125.4M | $-2.5M |
| FCF MarginFCF / Revenue | 16.5% | -0.4% |
| Capex IntensityCapex / Revenue | 5.6% | 10.3% |
| Cash ConversionOCF / Net Profit | 9.93× | 2.98× |
| TTM Free Cash FlowTrailing 4 quarters | $195.0M | $57.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.8M | $61.3M | ||
| Q3 25 | $72.1M | $148.7M | ||
| Q2 25 | $112.8M | $-19.1M | ||
| Q1 25 | $-51.1M | $109.1M | ||
| Q4 24 | $122.6M | $86.4M | ||
| Q3 24 | $71.1M | $85.3M | ||
| Q2 24 | $105.9M | $53.6M | ||
| Q1 24 | $-42.8M | $25.8M |
| Q4 25 | $125.4M | $-2.5M | ||
| Q3 25 | $47.4M | $79.3M | ||
| Q2 25 | $85.8M | $-69.5M | ||
| Q1 25 | $-63.6M | $50.1M | ||
| Q4 24 | $81.5M | $59.5M | ||
| Q3 24 | $46.1M | $79.4M | ||
| Q2 24 | $74.5M | $47.6M | ||
| Q1 24 | $-67.2M | $11.8M |
| Q4 25 | 16.5% | -0.4% | ||
| Q3 25 | 5.9% | 13.2% | ||
| Q2 25 | 9.9% | -12.8% | ||
| Q1 25 | -7.7% | 8.5% | ||
| Q4 24 | 10.9% | 12.4% | ||
| Q3 24 | 5.7% | 19.8% | ||
| Q2 24 | 8.8% | 15.1% | ||
| Q1 24 | -8.1% | 4.3% |
| Q4 25 | 5.6% | 10.3% | ||
| Q3 25 | 3.1% | 11.6% | ||
| Q2 25 | 3.1% | 9.3% | ||
| Q1 25 | 1.5% | 10.1% | ||
| Q4 24 | 5.5% | 5.6% | ||
| Q3 24 | 3.1% | 1.5% | ||
| Q2 24 | 3.7% | 1.9% | ||
| Q1 24 | 2.9% | 5.0% |
| Q4 25 | 9.93× | 2.98× | ||
| Q3 25 | 2.21× | 9.43× | ||
| Q2 25 | 2.14× | -0.45× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | 2.54× | 3.32× | ||
| Q3 24 | 1.86× | 1.13× | ||
| Q2 24 | 3.15× | 4.03× | ||
| Q1 24 | -0.87× | 2.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNT
| Color Additives And Inks | $466.0M | 61% |
| Specialty Engineered Materials | $295.5M | 39% |
HIMS
Segment breakdown not available.
